CoVid-19 patient diagnosis is currently performed almost exclusively by qPCR-based approaches. This is leading to a world wide restraint on patient testing and a global shortage in reagents required for such assays. We here propose to detect corona proteins instead, using mass spectrometry. We have already proved its applicability, and now need to scale up the assay.